StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA Premarket Approvals (PMA Original & Supplements) — Abbott

U.S. FDA openFDA PMA Database

QuarterlyAnnualMonthly
Latest, Sep 2026
19
Period ended Sep 30, 2026
Change on a year earlier
-20.8%
24 in Sep 2025
History
153 months
Since Jan 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA Premarket Approvals (PMA Original & Supplements) — AbbottYear on yearSource
Sep 2026Sep 30, 202619-20.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2026Aug 31, 202617-29.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2026Jul 31, 202629+38.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2026Jun 30, 202621-22.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
May 2026May 31, 202630+7.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Apr 2026Apr 30, 202624-25.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Mar 2026Mar 31, 202622+29.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Feb 2026Feb 28, 202639+30.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jan 2026Jan 31, 20269+50.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Dec 2025Dec 31, 202514-70.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Nov 2025Nov 30, 202510-47.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Oct 2025Oct 31, 202526-13.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Sep 2025Sep 30, 202524-22.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2025Aug 31, 202524+50.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2025Jul 31, 202521-12.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2025Jun 30, 202527+68.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA Premarket Approvals (PMA Original & Supplements) — Abbott, monthly Jan 2014–Sep 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-pma-co

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.